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Summary. The aim of this study was to characterize high exopolysaccharide (EPS)-producing lactic acid bacteria (LAB) 
isolated from mustard pickles in Taiwan for potential probiotic applications. Among 39 collected LAB strains, four most 
productive EPS-producing strains were selected for further analysis. Comparative analyses of 16S rDNA genes rpoA and pheS 
sequences demonstrated that these strains were members of Lactobacillus plantarum-group (LPG). NCD 2, NLD 4, SLC 13, 
and NLD 16 showed survival rates of 95.83% ± 0.49%, 95.07% ± 0.64%, 105.84% ± 0.82%, and 99.65% ± 0.31% under 
simulated gastrointestinal conditions, respectively. No cytotoxic effects on macrophage RAW 264.7 cells were observed when 
they were treated with a low dose (1 μg/ml) of stimulants extracted from the tested LAB strains. The production of nitric oxide 
in RAW 264.7 cells incubated with various LAB stimulants showed a dose-dependent increase. Among the four strains, SLC 
13 showed higher inhibitory activity on growth of Enterococcus faecalis (BCRC 12302) and Yersinia enterocolitica (BCRC 
10807). NLD 4 showed strong inhibitory activity against Escherichia coli O157:H7 (ATCC 43894) as compared with the other 
three strains. In summary, our results suggest that Lactobacillus pentosus SLC 13 may be a good candidate for probiotic appli-
cations and for development of antibacterial compounds. [Int Microbiol 20(2):75-84 (2017)]
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Introduction
The market of dietary supplements that promote health has 
increased since 1990s. Among them, probiotics are defined as 
live microorganisms that could confer a health benefit on the 
host when adequate amounts are administered [18]. Currently, 
the genera Lactobacillus (a member of the lactic acid bacteria 
(LAB) group) and Bifidobacterium are the most common pro-
biotics used for human nutrition. LAB generally have many 
useful properties, including tolerance to gastric acid and bile 
salts, tolerance to antimicrobial agents, improvement of im-
mune responses, gastrointestinal adsorption, and stability du-
ring processing [30]. Moreover, fermentation by the LAB 
group is a natural bioprocessing technology for production of 
foods such as milk, vegetables, yogurt, cheese, meat, and co-
coa beans. LAB-mediated fermentation thus improves nutri-
tion and preserves qualities of food and beverage products for 
long periods [7]. 
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The beneficial effects of LAB and its derivative exopo-
lysaccharide (EPS), include the prevention and treatment of 
diarrheal disease, prevention of infections, antitumor activity, 
immunomodulation, prevention and treatment of allergies, 
and alleviation of lactose intolerance [10,22,29,30,31,37]. In 
addition, the EPS produced by LAB is an important source of 
natural alternatives to various chemical compounds and plays 
a critical role in the production of fermented dairy products in 
Asia, Eastern Europe, and Northern Europe. However, the 
characteristics and production of EPS by LAB show a great 
variety, which depends on the type of LAB strains, culture 
conditions, and composition of the medium [14].
Mustard pickles, a vegetable processing product that is 
fermented by LAB and yeast, is an important dietary dish in 
Taiwan. Traditional processing of mustard pickles is as fo-
llows: whole mustard vegetables (Brassica juncea) are pac-
ked in layers with addition of solar salt to each vegetable la-
yer. Followed by placement of a large rock on top of the con-
tainer, the mustard inside the container is slowly pressed and 
fermented. In this study, we aimed to isolate and characterize 
LAB strains with potential probiotic applications from mus-
tard pickles. To our knowledge, this is the first report of cha-
racterization of EPS-overproducing LAB strains from mus-
tard pickles in Taiwan.
Materials and methods 
Sampling and isolation of lactic acid bacteria. Fifteen mustard 
pickle samples for LAB isolation were collected in traditional markets (Beipu 
Township, Hsinchu County, 4 samples and Meinong District, Kaohsiung 
City, 3 samples) and a mustard pickle production center (Dapi Township, 
Yunlin County, 8 samples) in Taiwan. The samples were transported to the 
laboratory at room temperature for isolating LAB in batches within 24 h of 
acquisition.
MRS (de Man, Rogosa, and Sharpe) agar plates were used for LAB iso-
lation. Each mustard pickle sample was crushed and mixed with phosphate-
buffered saline (PBS) buffer. A serial dilution of the suspension was spread 
onto the surface of MRS agar plates. Samples were then incubated under an-
aerobic conditions at 37 °C for 48 h. Six colonies were randomly selected 
from each MRS agar plates (total 90 colonies) and initially tested for acid 
production, catalase activity, bacterial motility, Gram staining, and cell mor-
phology. Among 90 colonies, a total of 39 LAB strains were isolated from 
mustard pickles. The selected strains were stored at –80 °C in MRS broth 
containing 16% glycerol until testing. 
Exopolysaccharide production analysis. The EPS production of 
isolated LAB strains was evaluated according to a previous study with a 
modification [17]. In brief, the liquid fermented by LAB was centrifuged at 
6000 ×g for 15 min after incubation for 48 h, and the resulting supernatant 
was collected carefully. An aliquot of the supernatant (1 ml) was mixed with 
4 ml of 95% ethanol, and then incubated at 4 °C for 24 h. The precipitated 
EPS was centrifuged at 9000 ×g for 15 min, and the supernatant was dis-
carded. The precipitate of pure EPS was dried in the oven at 60 °C for 24 h. 
The production of EPS was analyzed by the phenol-sulfuric method using 
glucose as a reference standard [35]. Among collected isolates, EPS yields 
were ranging from 0 to 0.43 ± 0.04 g/l. Four high EPS-producing LAB strains 
were further identified by means of the API 50 CH (BioMérieux, Marcy 
l’Etoile, France) strips and gene sequences (16S rDNA, rpoA, and pheS 
genes) to the species level [4].
DNA techniques. Mini Qiagen columns and a QiaAmp DNA extraction 
kit (Qiagen, Valencia, CA) were used for chromosomal DNA extraction. PCR 
was carried out according to the manufacturer’s instruction using Taq poly-
merase (Promega, Madison, WI, USA).
DNA sequencing and phylogenetic analysis. The sequence of 
16S rDNA gene, the housekeeping genes rpoA (the gene encoding the DNA-
dependent RNA polymerase alpha-subunit), and pheS (the gene encoding the 
phenylalanyl-tRNA synthase alpha-subunit) were used for phylogenetic anal-
ysis and species identification. Primers and conditions for PCR amplification 
of the 16S rDNA, rpoA, and pheS genes were described previously [4]. To 
draw a phylogenetic tree of the 16S rDNA, rpoA, and pheS genes, sequences 
were first aligned using the CLC Workbench (CLC sequence viewer 7.0, 
CLC Bio/Qiagen, Aarhus, Denmark), and the aligned file was then subjected 
to the neighbour-joining method to draw a phylogenetic tree with bootstrap 
analysis of 1000 replicates. 
Random amplified polymorphic DNA (RAPD)–PCR amplifi-
cation. Three different primers (primers B, 5′-AACGCGCAAC-3′; primer 
E, 5′-GGCGTCGGTT-3′; and primer F, 5′-GGCCACGGAA-3′) for RAPD–
PCR analysis used in this study were described previously [5]. In brief, the 
PCR mixtures were made in a volume of 50 μl containing 100 ng of DNA, 
10 pmol of primer, 0.15 mM each deoxynucleoside triphosphate, reaction 
buffer with MgCl2, and 1 U of Taq DNA polymerase. The cycling program 
consisted of 1 cycle of 94 °C for 5 min; 8 cycles of 94 °C for 30 s, 36 °C for 
1 min, and 72 °C for 90 s; 35 cycles of 94 °C for 20 s, 36 °C for 30 s, and 
72 °C for 90 s; and a final cycle of 72 °C for 3 min. The PCR products were 
electrophoretically separated in 1% agarose gels. The RAPD profiles were 
used to discriminate between the different isolates. 
Tolerance of simulated gastrointestinal conditions. To eval-
uate the survival of LAB strains in an environment that mimics in vivo human 
upper-gastrointestinal tract conditions, an in vitro methodology was used. For 
acid tolerance analysis, 0.1 ml of a LAB culture medium from an overnight 
culture was added to 9.9 ml of PBS (pH = 3). The mixture was incubated at 
37 °C with agitation (80 rpm) for 3 h. One milliliter of the culture medium 
was mixed with 9 ml of PBS, followed by serial dilution and spreading on 
MRS agar plates. The number of surviving bacteria was measured by the 
plate counts after 48-h incubation under anaerobic conditions. The survival 
rate of LAB strains under acidic conditions was calculated according to the 
following equation: 
Survival rate (%) = [A1(Log CFU/ml)/A0(Log CFU/ml)] × 100, where A1 
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is the viable count of LAB after 3 h at pH 3.0, and A0 is the viable count of 
LAB at 0 h. 
For analysis of bile salt tolerance, after acid treatment for 3 h, the surviv-
ing LAB were collected by centrifugation (7000 ×g, 5 min) and washed two 
times with PBS (pH 7.2). The bacteria were resuspended in 10 ml of MRS 
broth with or without 0.3% (w/v) bile salt, and then incubated at 37 °C for 
24 h under anaerobic conditions. One milliliter of the culture medium was 
mixed with 9 ml of PBS, followed by serial dilution and spreading on MRS 
agar plates. The number of surviving bacteria was determined by the plate 
counts after 48-h incubation under anaerobic conditions. The survival rate of 
LAB strains in the culture medium containing 0.3% of bile salt was calcu-
lated according to the following formula: 
Survival rate (%) = [B1(Log CFU/ml)/B0(Log CFU/ml)] × 100, where B1 
is the viable count of LAB in 0.3% bile salt for 24 h, and B0 is the viable count 
of LAB cultured without 0.3% bile salt for 24 h. 
In addition, the survival rate of the analyzed LAB strains under simulat-
ed gastrointestinal conditions (pretreatment with acid conditions before bile 
salt treatment) was calculated according to the following formula: 
Survival rate (%) = [C1(Log CFU/ml)/C0(Log CFU/ml)] × 100. where C1 is 
the viable count of LAB under simulated gastrointestinal conditions, and C0 
is the viable count of LAB at 0 h. 
Antibiotic sensitivity testing. Sensitivity to 15 selected antimicro-
bial agents was determined by the disk diffusion method on MRS agar 
plates as described elsewhere [39]. BD BBL Sensi-Discs (Becton Dickin-
son, Sparks, MD, USA) were used. We tested the antimicrobial agents am-
picillin, cefalotin, chloramphenicol, cloxacillin, erythromycin, gentamicin, 
kanamycin, novobiocin, penicillin G, polymyxin B, rifampicin, tetracy-
cline, neomycin, streptomycin, and vancomycin. All measurements were 
performed in triplicate. The interpretation of resistance to these antimicro-
bial agents was in accordance with the recommendations published else-
where [1,13,38]. 
Cell culture. RAW 264.7 (mouse macrophage cell line, BCRC 60001) 
and HT-29 (Human colon colorectal adenocarcinoma cell line, ATCC HTB-
38) were purchased from Bioresource Collection and Research Center (Hsin-
chu, Taiwan) and maintained in the DMEM complete medium and McCoy’s 
5A (modified) medium, respectively, supplemented with penicillin (100 IU/
ml), streptomycin (100 μg/ml), and 10% of fetal bovine serum at 37 °C with 
5% of CO2 supplemented in a humidified incubator. 
Bacterial adhesion assay. Bacterial adhesion assay was performed 
according to a previousd study with a modification [34]. HT-29 cells (1 × 105/
well) were grown overnight in 12-well culture dishes to approximately 80% 
confluence. Bacteria were added to the wells at a multiplicity of infection 
(MOI) of 100 without centrifugation and were incubated for 1 h. Each dish 
with HT-29 Lactobacillus co-culture was washed twice with prewarmed PBS 
buffer to remove unbound bacteria. Adhered Lactobacillus cells were quanti-
fied by lysing the cells for 2 min with 1% Triton X-100-containing PBS buf-
fer, followed by serial dilution and spreading on MRS agar plates. The num-
ber of adhered bacteria was measured by the plate counts after 3 days incuba-
tion. The percentage of bacterial adhesion was calculated according to the 
following formula: 
Adhesion ability (%) = (adhered bacteria)/(total bacteria) × 100 
Cell viability testing and nitric oxide (NO) production. For 
the treatment of RAW 264.7 cells, LAB stimulants were prepared from an 
overnight LAB culture. The culture medium was separated by centrifugation, 
and the pellet was washed with deionized water three times. The LAB stimu-
lants from the pellet were further sterilized, freeze-dried, mixed with a small 
amount of deionized water, and sterilized again. Cell viability was assessed 
by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay. RAW 264.7 cell cultures grown overnight at the density of 105 cells/ml 
were incubated with various concentrations of LAB stimulants (1, 10, 50, 100 
μg/ml) or lipopolysaccharide (LPS, 0.5 μg/ml) in 100 μl of the DMEM me-
dium for 24 h. After removal of the supernatant from the plate, the cells were 
incubated at 37 °C with 30 μl of MTT (5 mg/l) for 3 h. The medium was as-
pirated, and the crystals were dissolved in 200 μL of dimethylsulfoxide 
(DMSO). Absorbance of each well at 570 nm was measured using a micro-
plate reader. Cell viability was calculated using the following equation: 
Cell viability (%) = (Asample/Acontrol) × 100, where Asample is the absorbance 
of the cells that were incubated with the DMEM medium containing various 
concentrations of LAB stimulants or LPS (0.5 μg/ml), and Acontrol is the absor-
bance of the cells alone. 
The NO production assay was performed according to a previous study 
with a modification [16]. RAW 264.7 cells incubated overnight were sub-
cultured in 96-well plates at the density of 105/ml in 100 μl of the DMEM 
medium containing various concentrations of LAB stimulants (1, 10, 50, 
100 μg/ml) or LPS (0.5 μg/ml) for 24 h. The culture supernatants were col-
lected, and the NO production was measured by means of the Griess re-
agent. In brief, the supernatants were mixed with an equal volume of the 
Griess reagent (1:1 mixture of 0.1% N-1-naphthylethylenediamine in 5% 
phosphoric acid and 1% sulfanilamide in 5% phosphoric acid), and the 
samples were inoculated at room temperature with incubation for 15 min. 
The absorbance of each sample at 540 nm was measured using a microplate 
reader. NO production was calculated on the basis of a standard curve pre-
pared using sodium nitrite. 
The antibacterial-activity assay. The agar well diffusion meth-
od as described previously was applied to detect and determine the anti-
bacterial activities of the isolated LAB strains [36]. Staphylococcus au-
reus (BCRC 10908), Enterococcus faecalis (BCRC 12302), Streptococ-
cus mutans (BCRC 15254), and Listeria monocytogenes Scott A [3] were 
used as Gram-positive indicator strains, and Yersinia enterocolitica 
(BCRC 10807), Escherichia coli (BCRC 11634), Escherichia coli 
O157:H7 (ATCC 43894), and Salmonella enterica sv. Typhimurium 
(BCRC 10747) served as Gram-negative indicator strains. All indicator 
strains were incubated in Luria-Bertani (LB) broth overnight and then 
diluted to 107 CFU/ml with LB broth. The LB agar plates were prepared 
with five wells of 6 mm in diameter. A hundred microliters of the indica-
tor strains in LB broth was spread on the surface of an LB agar plate, 
followed by placing 50 μl of an overnight LAB culture medium into the 
wells. The LB agar plates were incubated at 37 °C for 24 h. The antibac-
terial activities of LAB strains were assessed by the diameter of the inhi-
bition zones. The interpretation of antibacterial activities of these LAB 
strains was as follows: < 10 mm (–) no antibacterial activity; 10–15 mm 
(+) weak antibacterial activity; > 15 mm (++) strong antibacterial activ-
ity. The antibacterial activity of each strain were evaluated in three inde-
pendent experiments. 
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Statistical analysis. The data were expressed as mean of three repli-
cates ± SD. Duncan’s multiple-range test was used to identify the significant 
differences (P < 0.05) between means. 
Results 
Isolation and characterization of LAB strains 
from mustard pickles. A total of 39 LAB strains were 
isolated from mustard pickles. Among them, 9, 23, and 7 
strains were isolated from Beipu Township, Dapi Township, 
and Meinong District, respectively. All isolates that showed 
characteristics of acid production and were catalase-negative, 
immotile, Gram-positive, and rod-shaped were assumed to be 
LAB. Among them, four high ESP-producing LAB strains 
were selected for further analyses (Table 1). The EPS produc-
tion of strains NCD 2, NLD 4, and NLD 16 isolated from 
mustard pickle samples from the Beipu Township was 0.34 ± 
0.04, 0.32 ± 0.02, and 0.35 ± 0.01 g/l, respectively (Table 1). 
The strain SLC 13 isolated from mustard pickles from the 
Meinong District produced the largest amount of EPS (0.43 ± 
0.04 g/l) among the 39 collected LAB isolates (Table 1). LAB 
strains isolated from mustard pickles of the Dapi Township 
showed little or no EPS production.
Identification of LAB from 16S rDNA, rpoA, 
and pheS sequences. Four isolated strains were further 
identified using the API 50 CHL species identification system, 
and the results showed that strains NCD 2 and SLC 13 belon-
ged to Lactobacillus plantarum, whereas strains NLD 4 and 
NLD 16 were Lactobacillus pentosus. Boyd et al. showed that 
the use of the current API 50 CH database for identification of 
Table 1. Characteristics, EPS production, acid and bile salt tolerance, and antibiotic sensitivity of the isolated LAB strains
LAB straina 
NCD 2 NLD 4 SLC 13 NLD 16
Sources in Taiwan Beipu Township, Hsin Chu Beipu Township, Hsin Chu Meinong District, Kaohsiung Beipu Township, Hsin Chu
16S rDNA, rpoA, and pheS 
genes identification
Lactobacillus plantarum Lactobacillus pentosus Lactobacillus pentosus Lactobacillus pentosus
EPS (g/l)b 0.34 ± 0.04b 0.32 ± 0.02b 0.43 ± 0.04a 0.35 ± 0.01b
Survival, pH 3.0 (% ± SD)b 73.73 ± 0.32c 88.32 ± 1.03b 99.37 ± 0.45a 87.36 ± 1.06b
Survival, 0.3% bile salt
(% ± SD)b
97.57 ± 0.74a 97.40 ± 1.23a 98.94 ± 0.31a 97.97 ± 0.62a
Survival, pH 3.0 + 0.3% 
bile salt (% ± SD)b














































































a Four isolated LAB strains showed characteristics of acid production, catalase negativity, a rod shape, immotility, and Gram-positive.
b Data are the mean of three replicates ± SD. Different letters indicate statistically significant differences at P < 0.05.
c S, sensitive; I, intermediate resistance; R, resistant.
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Fig. 1. Phylogenetic tree based on 16S rDNA, rpoA, and pheS sequences 
showing the relationship of strains NCD 2, NLD 4, SLC 13, and NLD16 
with strains of closely related species. The phylogenetic tree was constructed 
by the neighbour-joining method on the basis of a comparison of (A). 16S 
rDNA gene (1,362 nt), (B). rpoA (614 nt), and (C). pheS (335 nt). Bootstrap 
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commensal Lactobacillus species led to misidentification or 
uninterpretable results [2]. Therefore, 16S rDNA gene se-
quence of four isolates was used for species identification. 
The results showed that identical 16S rDNA gene sequence 
was observed between four isolated strains, L. plantarum 
JDM1 and L. plantarum WCFS1 (Fig. 1A). Currently, five 
different subspecies of L. plantarum-group (LPG) have been 
identified and are found to be closely related, which inclu-
des L. plantarum (subsp. plantarum and subsp. argentoraten-
sis), Lactobacillus pentosus, Lactobacillus paraplanta-
rum, Lactobacillus xiangfangensis, and Lactobacillus fabifer-
mentans [6]. Therefore, the sequences of rpoA and pheS genes 
of 4 isolated LPG strains were analyzed for subspecies identi-
fication. The results showed that high rpoA and pheS gene 
sequence similarities were observed between strains NLD4, 
SLC 13, NLD 16, and L. pentosus KCA1 (Fig. 1B and 1C). 
For discrimination of the isolates, RAPD fingerprinting was 
performed, and the results showed that four examined strains 
had different RAPD profiles (Fig. 2).
 
Survival under simulated gastrointestinal con-
ditions. To test the survival of the selected LPG strains 
under simulated gastrointestinal conditions, we used in 
vitro analysis which mimics the gastrointestinal condi-
tions in the body according to other studies [9,32]. PBS at 
pH 3.0 was used to simulate gastric juice and the 0.3% 
bile salt was used to simulate intestinal conditions. All 
four selected strains were resistant to bile salts, but only 
SLC 13 showed high resistance to pH 3.0 (Table 1). The 
results of survival testing under simulated gastrointestinal 
conditions were as follows: strains NCD 2, NLD 4, SLC 
13, and NLD 16 showed survival rates of 95.83% ± 0.49%, 
95.07% ± 0.64%, 105.84% ± 0.82%, and 99.65% ± 0.31%, 
respectively (Table 1).
Antibiotic susceptibility of the LPG strains. To 
examine the antibiotic sensitivity of the four LPG strains, we 
selected 15 antimicrobial agents for testing. All strains were 
resistant to penicillin G, vancomycin, polymyxin B, kanamy-
cin, neomycin, and streptomycin but sensitive to ampicillin, 
erythromycin, and chloramphenicol (Table 1). The SLC 13 
strain showed resistance to 12 selected antimicrobial agents 
but not to ampicillin, erythromycin, and chloramphenicol 
(Table 1).
Adhesion ability of isolated LPG strains. The ad-
hesion rates to HT-29 cells varied depending on the tested 
strains and ranged from 0.04 to 1.69% (Fig. 3). Among four 
examined strains, NLD 16 showed significantly better bin-
ding rates. The adhesion rates of strain NLD 4 were signifi-






ol Fig. 2. Genetic relatedness among the four LPG isolates by 
using RAPD-PCR analysis. Three primers with random se-
quences (B, E and F) were used. Marker, Thermo Scientific 
GeneRuler 1 Kb DNA ladder. 
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Effects of LPG stimulants on cell viability and 
NO production. On the basis of the observations that LPG 
stimulants have the ability to activate macrophages, we deter-
mined the potential effects of LPG stimulants on the cell viabi-
lity and NO production of RAW 264.7 cells. Clearly, treatment 
with LPS or a high dose of the stimulants significantly inhibi-
ted proliferation of these cells. In addition, stimulants from 
SLC 13 showed a stronger inhibitory effect (Fig. 4A). Never-
theless, no cytotoxic effects on macrophages were observed 
when the cells were treated with a low dose (1 μg/ml) of the 
stimulants (Fig. 4A).
RAW 264.7 cells were further incubated with different do-
ses of LPG stimulants, and the amount of NO in the culture 
supernatant was determined. RAW 264.7 cells in DMEM alo-
ne without either LPS treatment or bacterial stimulants served 
as a negative control. The results showed that when RAW 
264.7 cells were incubated with various bacterial stimulants, 
the production of NO increased in a dose-dependent manner 
(Fig. 4B). The stimulants from strain SLC 13 appeared to 
have a stronger effect on NO production than did the stimu-
lants from the other three strains (Fig. 4B). 
Antibacterial activity of the LPG strains against 
bacterial pathogens. Eight indicator pathogenic stra-
ins (four Gram-positive strains and four Gram-negative 
strains) were selected to evaluate the antibacterial activity 
of the four LAB strains. The results revealed that strains 
NCD 2, NLD 4, and SLC 13 had higher antibacterial acti-
vities (Table 2). Among them, SLC 13 showed higher in-
hibitory activity against the growth of E. faecalis and Y. 
enterocolitica. NLD 4 strain showed strong inhibitory ac-
tivity against E. coli O157:H7 compared with the other 







Fig. 3. Adhesion ability of four LPG isolates. The adhesion of LPG to HT-29 
cells with MOI 1 : 100 in four examined strains. Values are the average of 
at least three independent biological replicates. Each vertical bar represents 
mean ± SD (n ≥ 3). Different letters indicate statistically significant differen-







Fig. 4. Cell viability and NO production of RAW 264.7 cells treated with vari-
ous concentrations of LPG stimulants for 24 h. (A). Cell viability. (B). NO pro-
duction. Each vertical bar represents mean ± SD (n = 3). Cells treated with 
0.5 μg/ml LPS served as a positive control. NC, negative control (DMEM 
medium only). Different letters indicate statistically significant differences 
(P < 0.05).
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Discussion
Previous studies showed that the EPS production of LAB 
strains was highly variable and could be influenced by the ge-
notype and environmental conditions, such as pH, temperatu-
re, incubation time, and the medium [11,21,35]. In this study, 
we isolated four high EPS-producing LPG strains (Table 1). 
The factors that affect EPS production of selected LPG strains 
would be worth investigating for probiotic applications in the 
future.
Jiang et al. showed that EPS production was reduced in the 
variant strains compared with wild-type B. longum BBMN68, 
causing a reduction in the acid resistance of the variant [15]. 
The EPS production also contributes to bile tolerance in L. bre-
vis strains [33]. In the present study, we isolated four high 
EPS-producing LPG strains showing high tolerance to simula-
ted gastrointestinal conditions (Table 1). These results suggest 
that higher EPS production of selected LPG strains may pro-
tect bacteria from a harsh environment, and these strains may 
be used for probiotic development in the future. Mongkolrob 
et al. showed a possible correlation between antibiotic resis-
tance and biofilm formation in Burkholderia pseudomallei, in 
which the EPS was supposed to be the main component in 
creation of the diffusion barrier for the antibiotics [27]. As a 
result, whether the EPS production is associated with the anti-
biotic resistance in our four LPG strains remains to be verified. 
In addition, the composition of EPS of our selected strains is 
still unclear and thus worth investigating. 
Here, we showed the adhesion rates to HT-29 cells varied 
depending on the tested strains and ranged from 0.04 to 1.69% 
(Fig. 3). A previous study showed that Lactobacillus strains 
isolated from human fecal samples exhibited higher HT-29 
cell adhesion ability compared to the strain isolated from 
cheese [8]. Martin et al. showed that Lactobacillus strains iso-
lated from human intestinal origin presented higher affinity to 
HT-29 cells [24]. These results suggest that Lactobacillus stra-
ins isolated from human source have strong adhesin-receptor 
interaction for adapting to human cells.
In the presence of a pathogen, macrophages can engulf 
microorganisms, produce NO to kill the pathogens, present 
antigens to helper T cells, and further secrete proinflammatory 
cytokines such as IL-6 and TNF-α to activate the immune res-
ponse. In the present work, SLC 13 stimulants induced signi-
ficant NO production in RAW 264.7 cells. These findings su-
ggest that the possible mechanism of NO upregulation in ma-
crophages treated with SLC 13 stimulants may be mediated 
by the l-arginine pathway [8]. Nonetheless, the cellular 
component(s) of SLC 13 that activates RAW 264.7 cells has 
Table 2. Antibacterial activity of the four isolated LPG against eight indicator pathogenic strains
Inhibition levela
Pathogenic bacteria NCD 2 NLD 4 SLC 13 NLD 16
Gram-positive
 Staphylococcus aureus (BCRC 10908) ++ + ++ ++
 Enterococcus faecalis (BCRC 12302) – + ++ –
 Streptococcus mutans (BCRC 15254) + + + –
Listeria monocytogenes Scott A [3] + + + +
Gram-negative
 Yersinia enterocolitica (BCRC 10807) + + ++ +
 Escherichia coli (BCRC 11634) + + + –
 Escherichia coli O157:H7 (ATCC 43894) + ++ + +
 Salmonella enterica sv. Typhimurium (BCRC 10747) + + + +
aInhibition level was determined by the diameter of the inhibition zone: (–) < 10 mm; (+) 10–15 mm; (++) > 15 mm
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protective and critical role in human defense systems, whe-
reas overproduction of NO during inflammation may lead to 
cytotoxicity [28]. As a result, the use of the selected LPG stra-
ins that can induce macrophages producing appropriate levels 
of NO may potentially enhance an immune response of the 
host.
Here, we showed that strains NCD 2, NLD 4, and SLC 13 
had higher antibacterial activities (Table 2). L. plantarum has 
been demonstrated to produce bacteriocins, such as plantari-
cin NC8, plantaricin 35d, plantaricin W, plantaricin A, planta-
ricin C, and plantacin B, and thus to prevent the growth of 
some pathogenic bacteria [12,23,25,26]. Currently, whole ge-
nome sequences of L. plantarum L�206 and L. paraplanta-
rum L-�S9 strains were used to identify potential gene clus-
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rial activity, and immunopotentiating effect. Thus, we believe 
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our findings is necessary. 
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